DIMERIX LIMITED

1.96%

50.0¢

Market Cap $306.2M

Healthcare Biotechnology

Dimerix Limited is an Australia-based clinical-stage biopharmaceutical company. The... Dimerix Limited is an Australia-based clinical-stage biopharmaceutical company. The Company is focused on developing lives of patients with inflammatory diseases, including both kidney and respiratory diseases. It develops and commercializes patient preferred pharmaceutical products for global markets using its receptor technology to identify and develop drugs in areas with an unmet need. The Company is focused on developing its Phase III product candidate DMX-200 (QYTOVRA), for Focal Segmental Glomerulosclerosis (FSGS) kidney disease and is also developing DMX-700 for Chronic Obstructive Pulmonary Disease (COPD). Its Receptor Heteromer Investigation Technology (Receptor-HIT) is a scalable and globally applicable technology platform enabling the understanding of receptor interactions to rapidly screen and identify new drug opportunities. Its products target multiple global territories, with the initial focus predominantly on the United States and European markets. More

ASX:AFP

Could this ASX stock become the next Pfizer? A look at AFT Pharmaceuticals (ASX:AFP). With biotech stocks broadly having a strong run in 2025, and with more of the year ahead, investors are still looking for stocks in the sector with room to run.

Latest Threads

Tag

Subject

DXB

Ann: Dimerix to Present at Euroz Hartleys Healthcare Forum 2026

06/02/26

2.6K

06/02/26

Last post vintage

2.6K

DXB Medicine

DXB Media thread.

13 14 15

06/02/26

872

411K

06/02/26

Last post betheball

872

411K

DXB

General Discussion DXB

04/02/26

7.1K

04/02/26

Last post BT6487

7.1K

DXB

Filspari

2 3

03/02/26

122

24K

03/02/26

Last post CloseTheMarkets

122

24K

DXB

Ann: Quarterly Appendix 4C and Activities Report

30/01/26

9.5K

30/01/26

Last post Malzo

9.5K

DXB

Ann: Appointment of CFO/Company Secretary

27/01/26

6.4K

27/01/26

Last post offshoresa65s

6.4K

DXB

Broker Reports

4 5 6

21/01/26

312

85K

21/01/26

Last post altrincham

312

85K

DXB

Ann: Clinical trial update at J.P. Morgan Healthcare Conference

20/01/26

17K

20/01/26

Last post simons77

17K

See All Discussions

Timeline

Dimerix to Present at Euroz Hartleys Healthcare Forum 2026
05 Feb 09:26	Share

Quarterly Appendix 4C and Activities Report
29 Jan 09:39	Share

Appointment of CFO/Company Secretary
21 Jan 08:28	Share

Clinical trial update at J.P. Morgan Healthcare Conference
12 Jan 08:28	Share

Dimerix receives input from FDA on ACTION3 trial endpoints
24 Dec 08:36	Share

BioMarin to acquire Dimerix US Partner, Amicus Therapeutics
22 Dec 09:16	Share

DMX-200 ACTION3 Phase 3 Trial Completes Recruitment
15 Dec 08:45	Share

Change of Director's Interest Notice - CS,HA,NW,SP & MD
12 Dec 14:50	Share

Notification regarding unquoted securities - DXB
12 Dec 14:04	Share

Successful Completion of Planned IDMC Review
19 Nov 09:05	Share

Results of AGM
18 Nov 16:58	Share

Chair Address and AGM Presentation
18 Nov 12:58	Share

Quarterly Appendix 4C and Activities Report
29 Oct 08:35	Share

Cleansing Notice
22 Oct 16:20	Share

Application for quotation of securities - DXB
22 Oct 16:13	Share

Canaccord Drug & Device Conference Investor Presentation
21 Oct 08:31	Share

2025 AGM Notice of Meeting, Letter of Access and Proxy
16 Oct 09:03	Share

Successful PARASOL Collaboration Data Analysis Outcome
08 Oct 08:37	Share

DMX-200 receives Orphan Drug Designation in Japan
30 Sep 08:37	Share

Notification of Date of 2025 AGM
19 Sep 09:32	Share

Investor Presentation
03 Sep 09:07	Share

Appendix 4G and Corporate Governance Statement
28 Aug 09:29	Share

Appendix 4E and 2025 Annual Report
28 Aug 09:06	Share

Investor Presentation and Recording
19 Aug 08:57	Share

Cleansing Notice
12 Aug 15:08	Share

Application for quotation of securities - DXB
12 Aug 15:02	Share

Dimerix presentation at Bioshares Biotech Summit
07 Aug 09:05	Share

Quarterly Appendix 4C and Activities Report
25 Jul 08:35	Share

Change of Director's Interest Notice - SP
07 Jul 15:46	Share

Application for quotation of securities - DXB
01 Jul 12:23	Share

View More

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 50.0¢		Change -0.010(1.96%)		Mkt cap ! $306.2M

Open	High	Low	Volume
51.5¢	51.5¢	49.0¢	550.0K

Buyers (Bids)

Vol.	Price($)
107204	49.5¢

Sellers (Offers)

Price($)	Vol.
50.0¢	18451

Last trade - 10.59am 06/02/2026 (20 minute delay)

DXB (ASX) Chart

DIMERIX LIMITED

Latest Threads

Listen: HotCopper Wire Podcast #041 – Our first RBA rate hike since CY23

Timeline

Featured News

Latest Videos

Dimerix (ASX:DXB) to pocket $2.8m in R&D tax incentive prepayment

17 Feb 2023 10:56 (AEDT)

Dimerix (ASX:DXB) receives FDA approval to include teenagers in kidney disease study

12 Jan 2023 09:16 (AEDT)

Latest Articles

Dimerix launches key trial in Japan as recruitment kicks off

Dimerix (ASX:DXB) has kicked off a key trial in Japan (in terms of patient recruitment) seeking to treat inflammatory diseases.

Dimerix posts modest gain as first Japanese payment for DMX-200 lands

Dimerix has received the first multi-million dollar payment from its Japanese partner FUSO and expects those to continue.

Dimerix signs up first patient for 'highly significant' paediatric clinical trial

Dimerix Limited (ASX:DXB), a Melbourne-based biopharmaceutical company, has started recruitment for its first paediatric patient for the Phase 3 ACTION3 clinical trial in a major next step for the research.The trial will investigate the efficacy of DMX-200 in children aged 12 to 17 with focal seg...

Buyers (Bids)

Sellers (Offers)

Top Stories

Featured News